Across women’s health, trauma care, and complex chronic illness, Tracey’s observed how frequently patients—particularly women—fall through the cracks of conventional frameworks. When symptoms don’t fit neat diagnostic boxes, they are often fragmented, minimised, or attributed to stress. Hormonal shifts become “mood issues.” Insulin resistance becomes “lifestyle.” Autonomic instability becomes “anxiety.” Over time, patients internalise these explanations and lose trust in their own physiology.
Tracey’s clinical work, alongside her lived experience navigating systems that overlook complexity, shaped her commitment to doing this differently. She is interested in the patterns that don’t fit standard algorithms and the presentations that sit across pathways. Her approach centres on mechanism before judgement, collaborative reasoning over directive care, and restoring agency to people whose symptoms were previously dismissed. Complex bodies require expanded frameworks—not tighter ones.
Autonomic dysfunction disrupts nearly every body system. After viral illness or immune activation, this instability can persist, with patients frequently told their symptoms are stress-based or deconditioning-related. Hormonal shifts, inflammatory load, and metabolic stress can further amplify autonomic symptoms, creating overlapping patterns that are easily misread. Tracey works within subtype-aware POTS management, fluid and medication strategies, and coordinated hormonal support to reduce autonomic strain.
The endocannabinoid system plays a regulatory role in inflammation, pain modulation, sleep, mood, and autonomic balance. As an authorised prescriber, Tracey integrates tailored CBD with or without THC into broader treatment plans when clinically appropriate, particularly in pelvic pain, inflammatory conditions, sleep disruption, perimenopausal mood instability, and persistent pain syndromes.
Hormonal fluctuations alter autonomic function, insulin sensitivity, sleep architecture, mood stability, and inflammatory signalling. During perimenopause and menopause, shifting estrogen and progesterone levels can amplify anxiety, cognitive fog, joint pain, and dysautonomia, yet these changes are often treated in isolation or misattributed to primary psychiatric causes. Similarly, insulin resistance and metabolic dysregulation are frequently approached through restriction-based advice that fails to account for endocrine drivers. Tracey assesses hormonal and metabolic patterns together, using targeted hormone therapy, GLP-1 therapy, insulin-aware prescribing, and anti-inflammatory strategies that stabilise physiology rather than override it.
Trauma alters stress physiology, threat detection, and hormonal signalling, which in turn affects pain perception, sleep, immune response, and autonomic tone. In medical settings, lack of control or unclear communication can reactivate nervous system responses that complicate treatment. Compliance-driven models often fail because they overlook these physiological adaptations. Tracey practices with explicit consent, transparent reasoning, and shared decision-making to restore agency within care. When safety increases, physiological regulation often follows.